SCHEMBL8525865

SCHEMBL8525865

C=CC(=O)Oc1cc2c(Nc3ccc4[nH]ccc4c3)ncnc2cc1OCCCN1CCOCC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 15/20 0.57
SRC P12931 9/20 0.56
KDR P35968 8/20 0.56
ERBB2 P04626 5/20 0.56
KIT P10721 3/20 0.56
ERBB3 P21860 3/20 0.56
ERBB4 Q15303 3/20 0.56
LCK P06239 3/20 0.56
RET P07949 3/20 0.56
MET P08581 3/20 0.56
LTK P29376 3/20 0.56
MAP4K5 Q9Y4K4 3/20 0.56
FYN P06241 2/20 0.56
PDGFRA P16234 2/20 0.56
MAP2K2 P36507 2/20 0.56
MAP2K1 Q02750 2/20 0.56
BTK Q06187 2/20 0.56
TYRO3 Q06418 2/20 0.56
AURKB Q96GD4 2/20 0.56
CIT O14578 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7124677 0.88 EGFR (0.73) EGFRSRCKDRERBB2KIT
Hydrochloric Acid SCHEMBL4373085 0.86 SRC (0.72) EGFRSRCKDRERBB2KIT
SCHEMBL7127839 0.85 SRC (0.54) EGFRSRCKDRERBB2KIT
SCHEMBL7127833 0.84 EGFR (0.54) EGFRSRCKDRERBB2KIT
SCHEMBL8525415 0.83 EGFR (0.64) EGFRSRCKDRERBB2KIT
SCHEMBL8490274 0.83 EGFR (0.54) EGFRKDRERBB2RETFLT1
Hydrochloric Acid SCHEMBL4379495 0.83 SRC (0.74) EGFRSRCKDRERBB2KIT
SCHEMBL8525841 0.81 EGFR (0.61) EGFRSRCKDRERBB2KIT
SCHEMBL7117613 0.79 EGFR (0.58) EGFRSRCKDRERBB2KIT
SCHEMBL4371005 0.79 RET (0.66) EGFRKDRERBB2RETAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999006396-A1 IRREVERSIBLE BICYCLIC INHIBITORS OF TYROSINE KINASES WARNER-LAMBERT COMPANY (US) 1999-02-11 WO claimed
WO-1999006396-A1 IRREVERSIBLE BICYCLIC INHIBITORS OF TYROSINE KINASES WARNER-LAMBERT COMPANY (US) 1999-02-11 WO disclosed